摘要
汗管瘤指有导管(顶生)分化倾向的一组良性附件肿瘤。目前临床上将汗管瘤分为三型:①眼睑型;②发疹型;③局限型。可发生于任何年龄,半数以上患者发生于20~30岁。由于汗管瘤病程长,发展慢且不消退,给患者带来严重的精神负担,对患者的工作和生活产生负面影响。随着生活质量的提高,选择治疗的患者越来越多,但目前并没有一种非常有效的治疗方法。本文将总结近年来汗管瘤发病的影响因素,机制以及治疗方法,为汗管瘤的防治提供理论依据。
syringoma refers to a group of benign adnexal tumors with a ductal(terminal)differentiation.At present,the syringoma is divided into three types:①eyelid type②eruptive type③localized type,which can occur at any age,more than half of the patients occurred in 20 to 30 years old.Due to the long course of syringoma,slow development and non-extinction,severe mental depression is brought to the patients,which has a negative impact on the work and life of patients.With the improvement of quality of life,more and more patients are selected for treatment,but there is not a very effective treatment method at present.
作者
张金凤
康晨曦
蒋巧娜
侯恋恋
门可
ZHANG Jin-feng;KANG Chen-xi;JIANG Qiao-na;HOU Lian-lian;MEN Ke(School of public health,xi'an medical university,Shanxi Province,710021,China;Institute for research on health information and technology,school of public health,xi'an medical university,Shanxi Province,710021,China)
出处
《中国医疗美容》
2020年第6期143-148,共6页
China Medical Cosmetology
基金
陕西省教育厅专项科研计划项目(编号:16JK1660
2017PT21)
大学生创新创业训练计划项目(编号2018DC-05)
。
关键词
汗管瘤
影响因素
机制
治疗
syringoma
factor
mechanism
treatment
